(1) antiviral treatment to a patient showing signs and symptoms similar to herpes zoster, except where they are present in the head region;
(2) antiviral treatment against influenza to a symptomatic patient who is at risk of developing complications.
The pharmacist must then enter the reasons for initiating medication therapy on a form to be given to the patient. In addition, the pharmacist must refer the patient to a physician or specialized nurse practitioner:
(1) within 3 days after the initiation of the antiviral treatment against herpes zoster;
(2) 2 days after the initiation of the antiviral treatment against influenza, if the condition of the patient deteriorates.
(1) antiviral treatment to a patient showing signs and symptoms similar to herpes zoster, except where they are present in the head region;
(2) antiviral treatment against influenza to a symptomatic patient who is at risk of developing complications.
The pharmacist must then enter the reasons for initiating medication therapy on a form to be given to the patient. In addition, the pharmacist must refer the patient to a physician or specialized nurse practitioner:
(1) within 3 days after the initiation of the antiviral treatment against herpes zoster;
(2) 2 days after the initiation of the antiviral treatment against influenza, if the condition of the patient deteriorates.